Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis

E-ISSN： 1873-4286|19|20|3689-3712

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.20, 2013-06, pp. : 3689-3712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Invasive Aspergillosis: Focus on New Approaches and New Therapeutic Agents

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 1, 2002-01 ,pp. : 65-81

Bentham Science Publishers

Access to resources Recommend Favorite

Posaconazole clear choice for invasive fungal infection prevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Invasive Aspergillosis in Children and Adolescents

Current Pharmaceutical Design, Vol. 19, Iss. 20, 2013-06 ,pp. : 3545-3568

Bentham Science Publishers

Access to resources Recommend Favorite

Voriconazole: In the Treatment of Invasive Aspergillosis

By Muijsers R.B.R. Goa K.L. Scott L.J.

Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. : 2655-2664

Adis International

Access to resources Recommend Favorite

Bevacizumab: Invasive aspergillosis: case report

Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite